Translational research studies often investigate molecules in human tissues to better understand disease mechanisms or as either a measure of disease outcome or response to therapy. Blood is by far the most common tissue used, but in pediatrics it is often difficult to procure, mandating that best practices are used to yield quality samples for optimal study. [1] [2] [3] [4] Several factors can affect the quality of the blood samples, including the chosen container tubes, anticoagulants, preservatives and additives, processing times, centrifugation settings, shipping methods, storage variables, and freeze/thaw cycles. Poor attention to details or naive practices can negatively influence analyte stability and cellular integrity, potentially distorting the experimental results. 5 Furthermore, each biomarker or cell type has its own inherent properties, which may require protocol modifications for quality sample preservation.
In this review, our second in a series on tissue sampling and bio-banking for child health studies, 1 we present the pertinent issues that arise from blood collection, processing, shipping, and storage. Our goal is to highlight the different approaches and the best practices to maintain blood samples with the highest integrity. Pediatricspecific issues in translational research, such as study ethics, consent, and sampling volumes, were reviewed by us previously. 1 
BLOOD SAMPLE COLLECTION
Inaccurate experimental results are often secondary to inappropriate specimen collection and handling, or to interference factors. 6, 7 Laboratory measurements are influenced by hemolysis (high-negative-pressure blood draws or use of tourniquets), [7] [8] [9] [10] [11] lactescence (nonfasting patients), 12 concentration changes (drawing from an infusion line, insufficient filling of vials altering sample/additive ratio), 13, 14 bacterial contamination (production of ammonia or urea), 12 and extravascular interchange. 12 Providone-iodine solution used as a skin antiseptic can elevate phosphorus, uric acid, and potassium levels. 15 Blood draws from heparinized lines can falsely lower ionized calcium. 16 One of the earliest considerations is deciding whether unprocessed whole blood, plasma, or serum is required (Table 1) . Unprocessed whole blood requires no further processing once drawn from the patient and can be used for "point of care" testing (POCT). 17 POCT offer immediate results that not only can be used for rapid patient diagnostics but also to support research studies. Common POCT includes blood gases, electrolytes, hematocrit, glucose, creatinine, hemoglobin A1C, amylase, cardiac markers, coagulation markers, cholesterol, urinalysis, and streptococcal infection. POCT analyzers can provide precise results that correlate with results from the reference laboratory, 18, 19 but their accuracy relies on attention to quality control and operator training.
Unprocessed whole blood can be rapidly separated to yield either serum or plasma. Serum samples undergo the process of coagulation, which consumes all available clotting factors from the sample but can also impose artificial effects on the levels of biomarkers. In contrast, plasma is collected into tubes that contain anticoagulants to prevent the clotting of blood, and thereby retains clotting factors in solution. Centrifugation of unprocessed whole blood for plasma also results in isolation of a buffy coat layer, which can be used to produce cell concentrates (ie, leukocytes) for use in a wide array of in vitro studies or as a source of nucleic acids.
Although serum and plasma preparations are often used interchangeably, large differences exist between the proteomes of serum and plasma, making them incomparable to one another. 20 Hence, it is critical that either plasma or serum is exclusively chosen for study. Examples of biomarkers altered by blood processing are shown in Table 2 .
BLOOD COLLECTION TUBES
Evacuated tube systems for blood collection, such as Vacutainer (BD Biosciences, Franklin Lakes, NJ), are available for the isolation of serum, plasma, and buffy coat RNA or DNA. Frequently used blood collection tubes are summarized in Table 3 and should be chosen on the basis of the end-point assay.
Serum Isolation
Silicone-coated tubes contain a clot activator and are useful for serum chemistry.Alternatively,serum-separator tubes contain a gel barrier and decrease the incidence of hemolysis, increase sample stability, and facilitate primary tube sampling and storage. 21 Disadvantages of gel barrier tubes include instability under extreme temperatures 21 and barrier-induced changes in serum drug concentrations. 22 The type of serum collection tube that is selected can also have an effect on end-point analysis due to the differences in clotting facilitated by the additives. 23 Serum tubes may add unwanted polymeric components to the serum, leading to inaccurate results. 24 
Plasma and Buffy Coat Isolation
Citrate is a common anticoagulant used in plasma collection tubes, resulting in quality DNA and RNA isolation and high yields of lymphocytes that can be isolated for cell culture. 25, 26 Platelets are stable in citrate, 23, 27 releasing fewer small peptides into the plasma relative to other anticoagulants. 24 Heparin is an alternative anticoagulant used for plasma separation but may alter T-cell proliferation, 25, 26 antithrombin III activity, and protein interactions. 23, 27 Plasma isolated from tubes containing EDTA as an anticoagulant exhibits changes in protein profiles over time as compared with citrate. 23 
Blood Cell Concentrates
After density gradient centrifugation of whole blood, red blood cells can be isolated from the bottom fraction of the tube, and the buffy coat contains leukocytes and platelets. Further isolation of leukocyte subtypes is usually accomplished with density gradient centrifugation and/or antibody-coated beads. 28 Isolated leukocytes provide a means to assess the inflammatory response to disease. The type of anticoagulant, sample collection, and handling and processing techniques, however, can greatly affect the yield, quality, and morphology of isolated leukocytes and can produce sheer stress-induced shape changes, aggregation, and apoptosis. Cell activation, the stimulation of cellular processes initiated as a response to external stimuli, can also be instigated by anticoagulants and blood sampling. Activated neutrophils enhance phagocytotic activity, release lysosomal enzymes, increase cell migration, increase chemotaxis, and enhance cytotoxicity, 29 whereas activated macrophages/monocytes reduce motility, increase production and release of cytokines, increase synthesis of prostaglandins/leukotrienes, activate synthesis of plasminogen activator, enhance cytotoxicity against tumor cells, and increase procoagulatory activity. 30 Platelet isolation can result in cell activation, platelet-platelet and plateletleukocyte aggregation, accumulation of thrombin, and the release of inflammatory and mitogenic mediators. 31 Even though blood collected into EDTAcoated tubes is used clinically for platelet counts, EDTA can alter plasma protein content by instigating platelet clumping and aggregation. The latter Keep lag time before centrifugation constant to reduce sample variability 69, 70 Keep lag time before centrifugation constant to reduce sample variability 69, 70 Keep lag time before centrifugation constant to reduce sample variability 69, 70 Time to freeze Table 3 .
DETECTION OF IMMUNOGLOBULINS
Detection of infectious pathogens is often based on the determination of immunoglobulin antibodies in serum and plasma. 39 Immunoglobulins can be stable at room temperature (RT) for days, 25 but stability increases if serum aliquots are stored in dimethyl sulfoxide at 270°C. 25 The detection of immunoglobulins is altered by blood surfactants that may lead to the loss of antibody from the solid phase, affecting immunoassays during antibody diagnostics. 40,41 An alternative method for antibody diagnostics is the use of dried blood spots on either filter paper or Guthrie cards [42] [43] [44] ; blood must be dried for several hours at RT and then stored in sealed plastic envelopes at 220°C. [42] [43] [44] 
ISOLATION OF NUCLEIC ACIDS
Cell-free nucleic acids are present at low levels in the serum and plasma of healthy patients; however, illnesses result in a significant increase in nucleic acid blood levels. [45] [46] [47] [48] [49] Sources of cell-free nucleic acid include the apoptosis/necrosis of normal or cancer cells, or from microorganisms such as bacteria or viruses. 49 Therefore, the study of cell free nucleic acids in serum or plasma offers a valuable research opportunity in specific circumstances. Alternatively, DNA and RNA can be directly isolated from cellular Serum (due to coagulation process)
• VEGF is highly expressed in serum due to platelet secretion during clotting in both healthy patients 92 -94 and in those with disease [95] [96] [97] [98] [99] • MMPs increase with clot accelerators due to amorphous silica or silicate salts (components of clot activators) 100 • a-2 Macroglobulin, BDNF, EGF, ENA-78, IL-8, PAI-1, and TIMP-1 are higher in serum samples from healthy patients compared with plasma samples using EDTA, sodium citrate, or heparin as anticoagulant 101 • Lysophosphatidylcholines are higher in serum from healthy patients due to platelet release of phospholipases activated by thrombin 102 Plasma (due to the use of different anticoagulants or collection techniques)
• MMP-1, MMP-2, MMP-13, IL-4, IL-10, and growth factors increase in plasma isolated with EDTA
63
• Neutrophil elastase, MMP-2, and MMP-9 increase due to isolation-dependent activation of neutrophils and mononuclear phagocytes 33 , 65
• Troponin-I and troponin-T decrease in tubes with heparin due to binding 103 • Glucose is lower due to fluid shifting from erythrocytes to plasma caused by anticoagulants, 104 as compared with serum 102 • Total cholesterol is lower due to fluid shifting from erythrocytes to plasma with EDTA, as compared with serum
105
• HDL-C is higher in plasma due to EDTA, as compared with serum 105 • Lysophosphatidylcholines are higher due to the storage of plasma sample at RT a106
• FVIII levels decrease due to storage at RT before blood processing 107 • VEGF levels increase with EDTA as anticoagulant 108 • VEGF, MCP-1, eotaxin, and factor VII are increased in citrate and heparin plasma samples from healthy patients 101 BDNF, brain-derived neurotrophic factor; EGF, epidermal growth factor; ENA-78, epithelial neutrophil-activating peptide 78; FVIII, factor VIII; HDL-C, high-density lipoprotein cholesterol; IL, interleukin; MCP-1, monocyte chemotactic protein 1; MMP, matrix metalloproteinase; PAI-1, plasminogen activator inhibitor 1; TIMP-1, tissue inhibitor of metalloproteinase 1; VEGF, vascular endothelial growth factor. a RT = 20-25°C. High-quality DNA and RNA 25, 26 Produces high yield of lymphocytes for culture 25, 26 Can cause a dilution of the plasma Heparin (plasma) BD: Green top Plasma determinations in chemistry
Heparin binds to different cellular proteins, potentially interfering with downstream analysis [25] [26] [27] Heparin inhibits T-cell proliferation and culture efficacy 25, 26 Heparin Degradation of GLP-1 and GIP peptides were observed within 2-6 h in EDTA plasma, whereas P800 stabilized these peptides for 96 h. In EDTA, ghrelin half-life is 15.9 h, whereas in P800 its half-life is .3 d
123
The P800 tubes are compatible with proteomic analyses, including MALDI-MS, and immunoassays 123 ACE, angiotensin-corventing enzyme; BD, BD Biosciences; DPP-IV, proprietary dipeptidyl peptidase IV; ELISA, enzyme-linked immunosorbent assay; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, Glucagon-like peptide 1; K 2 EDTA, dipotassium EDTA; LC-MS, liquid chromatography-mass spectrometry; LFT, liver function test; MALDI-MS, matrix-assisted laser desorption/ ionization mass spectrometry; MALDI-TOF, matrix-assisted laser desorption/ionization time of flight; PPACK, D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone; 2D-PAGE, 2-dimensional polyacrylamide gel electrophoresis; PED, pediatrics; SCAT, special collection anticoagulant tubes; UE, Na, K, urea, creatinine.
fraction, often producing better yield and quality of nucleic acids than unprocessed whole blood. [50] [51] [52] [53] [54] Potential effects produced by different anticoagulants and processing techniques on DNA and RNA isolation are summarized in Table 7 .
DNA Isolation
Proper practice is crucial to ensure quality DNA isolation. 55 Commercial kits exist for DNA extraction from serum and plasma, which rely on similar methodologies and produce equivalent yields of DNA. 56 The QIAamp Viral Spin kit (Qiagen, Venlo, Netherlands), using silica-based membrane chemistry, is reported to produce high-yield DNA from plasma and serum. 57 The ReliaPrep Blood gDNA Miniprep System, based on cellulose-based chemistry, and the Maxwell 16 LEV Blood DNA Kit, based on paramagnetic particle chemistry, provide all-in-one methodologies for DNA purification from either blood or buffy coat (Promega, Fitchburg, WI). The quality and yield of DNA 58 can also be obtained inexpensively with traditional phenol/ chloroform extraction procedures, but these extractions are time consuming and labor intensive. Tubes containing citrate or EDTA are optimal choices for the isolation of cell-free DNA. 57 Alternatively, the PAXgene Blood DNA System is available for collection and stabilization of whole blood for isolation of genomic DNA.
RNA Isolation
It is imperative to prevent degradation of RNA during collection, transport, storage, and processing. 59 Commercial kits, using similar methodologies, are available for RNA isolation from blood or cellular fractions with similar efficiency. All kits are intended for easy collection, storage, and transport of blood while maintaining RNA stability, followed by the isolation and purification of RNA. Choices include the QIAamp UltraSens Virus Kit (Qiagen) for isolating mRNA from plasma 60 or several alternative kits depending on the type of isolation method, the preparation time, and the type of stabilization reagents (RNAlater, Tempus, PAXgene, EDTA, citrate or heparin tubes; Life Technologies, Carlsbad, CA). BD Vacutainer CPT cell preparation tubes are also available to isolate RNA.
TIMING OF SAMPLE PROCESSING
Blood components are labile in nature, and their integrity requires timely processing. For serum separations, the time allowed for samples to clot is critical, although it varies between samples on the basis of intrinsic clotting factor levels and clinical exposure to anticoagulants. Incubation times longer than required for adequate clotting may result in cell lysis, thereby altering analyte levels. 61 Higher molecular weight proteins, such as lipoproteins, are more sensitive to prolonged clotting time, resulting in potential variability. 62 Plasma samples do not require time to clot but require rapid processing to limit biomarker alterations. 63 Cytokine concentrations in plasma change in ,2 hours when maintained at RT. 25, 63, 64 In general, nucleic acids should be processed quickly to optimize yield and integrity. 58 Ideally, blood should be processed and frozen rapidly after collection. 63, 65 Placing samples on ice before processing can improve sample preservation; however, samples should still be processed within 30 to 60 minutes to maintain integrity. 66 Furthermore, the use of ice or cold packs in the transport of blood from the clinical setting to the laboratory can reduce protein degradation. 67 Temperature consistency of samples during processing is imperative to maintain sample quality. 68 It is also important to maintain consistent lag times between sample collections and processing, 125, 126 ; EDTA at recommended concentrations produces high-quality blood smears if they are made within 2-3 h of the blood draw 127 Effect on cell chemistry
• Sodium citrate: RBC morphology unchanged on peripheral blood smear 124 Effect on sample handling or collection
• CPD: the levels of lysolecithins (lysoPCs, compounds derived from phosphatidylcholines) are similar between fresh and 5-7-d RBC stored samples 106 • Sodium citrate: suitable anticoagulant for routine hematologic analysis on the CELL-DYN 4000 system 124 • Oxalate: provides the best RBC labeling compared with ACD, heparin, or sodium oxalate (0.13 mmol/L stannous chloride assay) 128 • EDTA: the labeling of RBCs is lower compared with other anticoagulants, likely due to its high chelating capacity 128 • Heparin: interferes with Wright' s stain 124 • RBC number and 2,3-DPG content decrease in whole blood at RT a for 24 h; lactate, potassium, and hemolysis increase, whereas pH, RBC ATP, glucose, and sodium concentrations decrease 129 ACD, acid citrate dextrose; ATP, adenosine-59-triphosphate; CPD, citrate-phosphate-dextrose; RBC, red blood cell; 2,3-DPG, 2,3-diphosphoglycerate. a RT = 20-25°C.
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STORAGE TEMPERATURE
Storage temperatures depend on the nature of the analyte that is being preserved. Although DNA isolated from blood samples is stable at 4°C for several weeks, at 220°C for months, and at 280°C for years, 71 RNA degrades quickly at temperatures higher than 2 80°C. 25 Proteins and other soluble biomarkers have varied stability; immunoglobulins are stable at RT for days, 25 whereas other proteins are exceedingly labile and must be frozen at 280°C. 68, 72 Viable cells can typically survive at RT for #48 hours, but they must be eventually cultured at physiologic temperatures or frozen in liquid nitrogen with a cryoprotective agent for long-term preservation. 73, 74 In general, 280°C is usually sufficient to preserve a broad range of molecules. Protein profiling is preserved for $4 years of storage at 270°C. 75, 76 Nonetheless, the long-term stability of many molecules is poorly understood, and long-term storage of samples should be limited to ,4 years from sample procurement.
FREEZE-THAW OF SAMPLES
Although frozen samples are stable for long-term storage, they are especially vulnerable to freeze-thaw cycles. Freeze-thawing results in the formation of ice crystals, which can cause significant destruction to biological molecules. A single freeze-thaw at 270°C decreases the yield of DNA by 25%, 77 and multiple freeze-thaw cycles can influence many other molecules. 67, 76, 78, 79 Freeze-thaw damage is limited by aliquoting samples into small volumes that are sufficient for a single experimental, and then flash-freezing samples with either liquid nitrogen or by cooling ethanol on dry ice for tube submersion. 80 SHIPMENT Blood specimens, with or without infectious agents, are considered dangerous goods and must be properly classified, identified, packed, labeled, and handled for shipping. 81 Various agencies have published rules and regulations regarding the transportation of medical specimens on the basis of the associated risks and safety standards, 82 and they also provide training and expert advice on dangerous goods transportation. International Air Transport Association (IATA) guidelines for transport of dangerous goods 83 as well as local laboratory protocols must be followed.
Specimens must be kept within a specific temperature range during shipment to protect sample integrity. Temperature maintenance and packaging depend on the nature of the sample and the proposed analysis. Samples can be shipped at RT (20-30°C), refrigerated (2-8°C), or frozen (220°C, 270°C, 2150°C). Shipping boxes and packs to maintain specific temperatures, in addition to absorbent strips, bubble wrap, and polypropylene secondary-pressure vessels with Orings for leak-proof packaging, are available. Samples that should be maintained below 270°C require dry • Heparin: increases PMN activation due to stimulation of adhesion molecules such as integrins 135 
Monocytes
Effect on cell morphology and on sample handling or collection
• EDTA: vacuolization of monocytes occurred after 1 h of storage at RT and increased after 4 h
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; no or minimal changes were found when samples were stored at 4°C 132 Effect on cell chemistry
• EDTA and heparin: increases the number of monocytes isolated, but they did not affect monocyte viability, spontaneous migration, chemotaxis, phagocytosis, or in killing Candida albicans ice in the shipping box, whereas a liquid nitrogen dry shipper must be used for samples shipped at 2150°C. Shipping of frozen specimens with dry ice requires "UN" dry ice labeling on the box, including the name and addresses of shipper and consignee, and the weight of the dry ice must be marked near the class 9 diamond-shaped hazard label.
Specimens are designated category "A" if they are blood samples or cultures known to contain certain infectious agents or category "B" if they are blood specimens typical of clinical diagnostic tests. Specific leak-proof containers for specimens classified as A or B are available commercially.
Category A specimens must be shipped in a certified container according to IATA regulations. Several commercial laboratories offer a variety of infectious certified containers for frozen, refrigerated, or ambient specimens that include secondary and outer packages and in most cases contain the appropriate hazard labels. Category A specimens are assigned to UN2814-Infectious Substance, affecting humans. The assignment to UN2814 is based on the medical history of the patient or by his or her symptoms. If it is not clear whether a pathogen falls within this category, it must be transported labeled as a Category A Infectious Substance. To help with the assignment, the IATA has created a 25, 26 • Heparin: should be avoided, because it can inhibit downstream PCR reactions 89 • DNA extraction method using dried blood spots on filter paper provides a reliable molecular diagnosis of viral and parasite infections 50, 144 • DNA from whole-blood samples should not be frozen before DNA isolation, because hemolysis can inhibit PCR reactions 
